Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where James F. Blake is active.

Publication


Featured researches published by James F. Blake.


Archive | 2007

Heterobicyclic pyrazole compounds and methods of use

James F. Blake; Steven Armen Boyd; Jason De Meese; Kin Chiu Fong; John Gaudino; Tomas Kaplan; Allison L. Marlow; Jeongbeob Seo; Allen A. Thomas; Hongqi Tian; Frederick Cohen; Wendy B. Young


Archive | 2008

Pyrimidyl cyclopentanes as AKT protein kinase inhibitors

Josef R. Bencsik; James F. Blake; James M. Graham; Martin F. Hentemann; Nicholas C. Kallan; Ian S. Mitchell; Stephen T. Schlachter; Keith L. Spencer; Dengming Xiao; Rui Xu; Mike Welch; Jun Liang; Brian Safina


Archive | 2007

Hydroxylated and methoxylated cyclopenta[d]pyrimidines as akt protein kinase inhibitors

Ian S. Mitchell; James F. Blake; Rui Xu; Nicholas C. Kallan; Dengming Xiao; Keith L. Spencer; Josef R. Bencsik; Jun Liang; Brian Safina; Birong Zhang; Christine Chabot; Steven Do; Eli W. Wallace; Anna L. Banka; Stephen T. Schlachter


Archive | 2009

5h-cyclopenta[d]pyrimidines as akt protein kinase inhibitors

Anna L. Banka; Josef R. Bencsik; James F. Blake; Martin F. Hentemann; Nicholas C. Kallan; Jun Liang; Ian S. Mitchell; Stephen T. Schlachter; Eli M. Wallace; Rui Xu; Tony P. Tang


Archive | 2014

SERINE/THREONINE KINASE INHIBITORS

James F. Blake; Mark Joseph Chicarelli; Rustam Ferdinand Garrey; John Gaudino; Jonas Grina; David Moreno; Peter J. Mohr; Li Ren; Jacob B. Schwarz; Huifen Chen; Kirk Robarge; Aihe Zhou


Archive | 2012

Quinazoline compounds as serine/threonine kinase inhibitors

James F. Blake; Huifen Chen; Mark Joseph Chicarelli; Jason Demeese; Rustam Ferdinand Garrey; John Gaudino; Lewis J. Gazzard; Robert J. Kaus; Samuel Kintz; Peter J. Mohr; David Moreno; Jacob B. Schwarz; Christopher S. Siedem; Eli M. Wallace


Archive | 2009

Hydroxylated pyrimidyl cyclopentane as akt protein kinase inhibitor

Josef R. Bencsik; James F. Blake; Nicholas C. Kallan; Ian S. Mitchell; Keith L. Spencer; Dengming Xiao; Rui Xu; Christine Chabot; Steven Do; Jun Liang; Brian Safina; Birong Zhang; James M. Graham


Archive | 2009

Hydroxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors

Josef R. Bencsik; James F. Blake; Nicholas C. Kallan; Ian S. Mitchell; Keith L. Spencer; Dengming Xiao; Rui Xu; Christine Chabot; Steven Do; Jun Liang; Brian Safina; Birong Zhang


Archive | 2012

Substituted quinazolines as serine/threonine kinase inhibitors

James F. Blake; Huifen Chen; Mark Joseph Chicarelli; Jason Demeese; Rustam Ferdinand Garrey; John Gaudino; Lewis J. Gazzard; Robert J. Kaus; Samuel Kintz; Peter J. Mohr; David Moreno; Jacob B. Schwarz; Christopher S. Siedem; Eli M. Wallace


Archive | 2008

Pyrimido cyclopentanes useful for the treatment of inflammatory or hyperproliferative diseases

Josef R. Bencsik; James F. Blake; James M. Graham; Martin F. Hentemann; Nicholas C. Kallan; Ian S. Mitchell; Stephen T. Schlachter; Keith L. Spencer; Dengming Xiao; Rui Xu; Mike Welch; Jun Liang; Brian Safina

Collaboration


Dive into the James F. Blake's collaboration.

Researchain Logo
Decentralizing Knowledge